People who took Elmiron, a medication that treats symptoms of interstitial cystitis, are filing lawsuits against Janssen Pharmaceuticals after they suffered vision problems that could lead to blindness, including maculopathy. Elmiron lawsuits allege Janssen failed to warn doctors and patients that Elmiron side effects included vision damage. Lawsuits also claim Elmiron is a dangerously defective drug and the drugmaker withheld adverse event reports from the public, medical community and FDA. People file Elmiron lawsuits for potential compensation for medical bills, pain and suffering, lost wages, loss of quality of life and future care.
Do I Qualify for an Elmiron Lawsuit?
Lawyers are accepting cases from people who took Elmiron for at least two years and suffered vision problems, especially if they were still using Elmiron from 2018 to present.
These vision problems must have started while taking Elmiron or within one year of stopping treatment. For example, if you stopped taking Elmiron in 2010 and got a diagnosis of an eye condition in 2011, you may qualify.